Literature DB >> 236737

Evaluation of the Nissen fundoplication for treatment of hiatal hernia: use of parietal cell vagotomy without drainage as an adjunctive procedure.

K Bahadorzadeh, P H Jordan.   

Abstract

Twenty-nine patients who underwent Nissen fundoplication for the treatment of symptomatic, sliding, esophageal hiatal hernia are reported. Fourteen of these patients also underwent parietal cell vagotomy (PCV) without a drainage procedure. Simulatenous cineradiography and manometric studies, esophagoscopy and gastric analysis were performed pre- and postoperatively. Esophageal acid clearing and pH reflux studies were performed postoperatively. All but 3 patients had reflux and/or esophagitis preoperatively. Cineradiography and the pH reflux test were the most reliable tests for diagnosis of reflux. There was no operative mortality. The mean followup period was 20 months. Dysphagia occurred in 5 patients. Correction of dysphagia in one patient required operation. The dysphagia in the remaining patients was temporary and mild, responding to dilatation. Two patients had mild diarrhea. One patient who had had a previous gastric resection developed severe diarrhea after bilateral truncal vagotomy. No patient developed the "bloat syndrome". A close correlation did not exist between reflux and preoperative sphincter pressure. The mean LES pressure increased 10 mmH2O postoperatively and the two patients with persistent reflux postoperatively had normal LES pressure. Correction of reflux after Nissen fundoplication is probably due to some mechanism other than increased LES pressure. Recurrent or persistent hiatal hernia was diagnosed in 4 patients by cineradiography. Two of these patients had reflux but only the patient who had undergone PCV was without symptoms or esophagitis. The technical performance of the Nissen hiatal hernia repair was greatly facilitat ed by PCV. This procedure also provided adequate treatment for patients with concomitant duodenal ulcer disease. PCV, unaccompanied by a drainage procedure, was not associated with increased morbidity, mortality or the adverse effects usually attributed to vagotomy. In the event of recurrent hernia and reflux, PCV may prevent the development of esophagitis.

Entities:  

Mesh:

Year:  1975        PMID: 236737      PMCID: PMC1343778          DOI: 10.1097/00000658-197504000-00006

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  32 in total

1.  Reminiscences--reflux esophagitis and hiatal hernia.

Authors:  R Nissen
Journal:  Rev Surg       Date:  1970 Sep-Oct

Review 2.  A survey of techniques and results of hiatus hernia repair.

Authors:  R A Mustard
Journal:  Surg Gynecol Obstet       Date:  1970-01

3.  Nissen fundoplication and esophagitis secondary to gastroesophageal reflux.

Authors:  W S Battle; L M Nyhus; C T Bombeck
Journal:  Arch Surg       Date:  1973-04

4.  Gastroesophageal reflux: diagnosis and treatment.

Authors:  W S Battle; L M Nyhus; C T Bombeck
Journal:  Ann Surg       Date:  1973-05       Impact factor: 12.969

5.  Preoperative manometry in the choice of operations for gastroesophageal reflux.

Authors:  C T Bombeck; W S Battle; L M Nyhus
Journal:  Am J Surg       Date:  1973-01       Impact factor: 2.565

6.  Comparison of crural repair and Nissen fundoplication in the treatment of esophageal hiatus hernia with peptic esophagitis.

Authors:  E R Woodward; H F Thomas; J C McAlhany
Journal:  Ann Surg       Date:  1971-05       Impact factor: 12.969

7.  Assessment of distal esophageal function in patients with hiatal hernia and-or gastroesophageal reflux.

Authors:  D B Skinner; D J Booth
Journal:  Ann Surg       Date:  1970-10       Impact factor: 12.969

8.  Surgical management of esophageal reflux and hiatus hernia. Long-term results with 1,030 patients.

Authors:  D B Skinner; R H Belsey
Journal:  J Thorac Cardiovasc Surg       Date:  1967-01       Impact factor: 5.209

9.  The association of symptomatic hiatus hernia and pyloric pathology.

Authors:  F Paulino; A Roselli
Journal:  Am J Gastroenterol       Date:  1970-12       Impact factor: 10.864

10.  The hiatal hernia-reflux complex. Current approaches to correction and evaluation of results.

Authors:  J M Moran; C O Pihl; R A Norton; H F Rheinlander
Journal:  Am J Surg       Date:  1971-04       Impact factor: 2.565

View more
  8 in total

1.  Surgery for gastro-oesophageal reflux: the Angelchik prosthesis compared to the floppy Nissen fundoplication. Two-year follow-up study and a five-year evaluation of the Angelchik prosthesis.

Authors:  T C Dehn
Journal:  Ann R Coll Surg Engl       Date:  1990-01       Impact factor: 1.891

Review 2.  Current status of parietal cell vagotomy.

Authors:  P H Jordan
Journal:  Ann Surg       Date:  1976-12       Impact factor: 12.969

3.  Effective of highly selective vagotomy upon the lower oesophageal sphincter.

Authors:  J G Temple; R J Goodall; D J Hay; D Miller
Journal:  Gut       Date:  1981-05       Impact factor: 23.059

4.  Antireflux surgery for symptomatic gastroesophageal reflux: mechanism of action.

Authors:  R S Fisher; L S Malmud; I F Lobis; W P Maier
Journal:  Am J Dig Dis       Date:  1978-02

5.  Gastroesophageal scintigraphy to assess the severity of gastroesophageal reflux disease.

Authors:  R A Menin; L S Malmud; R P Petersen; W P Maier; R S Fisher
Journal:  Ann Surg       Date:  1980-01       Impact factor: 12.969

6.  Vagotomy during hiatal hernia repair: a benign esophageal lengthening procedure.

Authors:  Brant K Oelschlager; Kyle Yamamoto; Todd Woltman; Carlos Pellegrini
Journal:  J Gastrointest Surg       Date:  2008-05-08       Impact factor: 3.452

7.  Necrosis of intraabdominal esophagus and proximal third of the stomach after proximal gastric vagotomy and fundoplication.

Authors:  C Ackermann; C Müller; F Harder
Journal:  World J Surg       Date:  1990 Jan-Feb       Impact factor: 3.352

8.  Indications for parietal cell vagotomy without drainage in gastrointestinal surgery.

Authors:  P H Jordan
Journal:  Ann Surg       Date:  1989-07       Impact factor: 12.969

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.